logo

For the Inventor, By the Inventor

Courbevoie, France

Bruno Tocque

This inventor holds 15 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Exonhit Therapeutics, Sa, Rhone-Poulenc Rorer S.a., Aventis Pharma S.a.. Active years: 1997-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Tocque. Retrieved from https://idiyas.com/inventor/bruno-tocque

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 86.7


Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 104(Granted Patents)


Location History:

  • Paris, FR (1997 - 2001)
  • Courbevoie, FR (1997 - 2011)

Company Filing History:

goldMedal5 out of 25 
 
Exonhit Therapeutics, Sa
 patents
silverMedal5 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents
bronzeMedal4 out of 377 
 
Aventis Pharma S.a.
 patents
4. 1 out of 1,853 
 
National Institute of Health and Medical Research
 patents
5. 1 out of 38 
 
Rhone Poulenc Rorer
 patents
6. 1 out of 5,633 
 
The University of Texas System
 patents
where one patent can have more than one assignee

Years Active: 1997-2011

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8003375 - Qualitative differential screening (2011-08-23),
2. 7884082 - Combined therapeutical treatment of hyperproliferative diseases (2011-02-08),
3. 6881571 - Qualitative differential screening (2005-04-19),
4. 6544948 - &Dgr;P62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer (2003-04-08),
5. 6509153 - Genetic markers of toxicity preparation and uses (2003-01-21),
6. 6372432 - Methods and composition for the detection of pathologic events (2002-04-16),
7. 6262032 - Method of destroying hyperproliferative cells by combined p53 and taxoid treatment (2001-07-17),
8. 6251590 - Differential Qualitative screening (2001-06-26),
9. 6180362 - Peptides which inhibit ras protein activity, their preparation and use (2001-01-30),
10. 6159947 - Anti-RAS intracellular binding proteins and use thereof (2000-12-12),
11. 6028245 - Transgenic animals overexpressing MDM2 (2000-02-22),
12. 5886150 - Peptides capable of binding to the GAP protein SH3 domain, nucleotide (1999-03-23),
13. 5831048 - Grb3-3 cDNA and polypeptides (1998-11-03),
14. 5656595 - Peptides having GDP exchange factor activity, nucleic acid sequences (1997-08-12),
15. 5637456 - Rapid test for determining the amount of functionally inactive gene in a (1997-06-10),

Title: The Innovative Journey of Bruno Tocque

Introduction: Bruno Tocque, a visionary inventor hailing from Courbevoie, France, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Bruno Tocque's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and a sustainable energy solution that harnesses solar power in urban environments.

Career Highlights: With a career spanning over two decades, Bruno Tocque has established himself as a leading figure in the field of sustainable technology. His work has been recognized globally for its impact on environmental conservation and energy efficiency.

Collaborations: Throughout his career, Bruno Tocque has collaborated with top research institutions and leading tech companies to bring his inventions to life. His partnerships have led to the development of cutting-edge solutions that address pressing challenges in today's society.

Conclusion: Bruno Tocque's relentless pursuit of innovation and commitment to sustainability have solidified his reputation as a trailblazer in the world of technology. His passion for creating a better future through invention continues to inspire generations of inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…